{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:04:19Z","timestamp":1767625459048},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00787-006-0506-y","type":"journal-article","created":{"date-parts":[[2006,3,7]],"date-time":"2006-03-07T16:09:51Z","timestamp":1141747791000},"page":"105-110","source":"Crossref","is-referenced-by-count":53,"title":["Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit\/hyperactivity disorder"],"prefix":"10.1007","volume":"15","author":[{"given":"Philip","family":"Hazell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Wola\u0144czyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Zuddas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Danckaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrula","family":"Ladikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Benn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roni","family":"Yoran-Hegesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pal","family":"Zeiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"506_CR1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/1469-7610.00424","volume":"40","author":"Angold","year":"1999","unstructured":"Angold A, Costello EJ, Erkanli A (1999) Comorbidity. J Child Psychol Psychiatry 40:57\u201387","journal-title":"J Child Psychol Psychiatry"},{"key":"506_CR2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/1469-7610.00127","volume":"44","author":"Banaschewski","year":"2003","unstructured":"Banaschewski T, Brandeis D, Heinrich H, Albrecht B, Brunner E, Rothenberger A (2003) Association of ADHD and conduct disorder\u2014brain electrical evidence for the existence of a distinct subtype. J Child Psychol Psychiatry 44:356\u2013376","journal-title":"J Child Psychol Psychiatry"},{"key":"506_CR3","first-page":"i102","volume":"13","author":"Banaschewski","year":"2005","unstructured":"Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A (2005) Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry 13(Suppl 1):i102\u2013i116","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"506_CR4","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1542\/peds.110.6.e75","volume":"110","author":"Biederman","year":"2002","unstructured":"Biederman J, Heiligenstein JH, Faries DE, Galil N, Dittmann R, Emslie GJ, Kratochvil CJ, Laws HF, Schuh KJ, Atomoxetine ADHD Study Group (2002) Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit\/hyperactivity disorder. Pediatrics 110:e75","journal-title":"Pediatrics"},{"key":"506_CR5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1176\/appi.ajp.159.1.36","volume":"159","author":"Biederman","year":"2002","unstructured":"Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, Wilens TE, Frazier E, Johnson MA (2002) Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 159:36\u201342","journal-title":"Am J Psychiatry"},{"key":"506_CR6","doi-asserted-by":"crossref","unstructured":"DuPaul GJ, Power TJ, Anastopoulos AD, Reid R (1998) ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretations. The Guilford Press, New York","DOI":"10.1037\/t00680-000"},{"key":"506_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0006-3223(00)00230-4","volume":"48","author":"Faraone","year":"2000","unstructured":"Faraone SV, Biederman J, Monuteaux MC (2000) Attention-deficit disorder and conduct disorder in girls: evidence for a familial subtype. Biol Psychiatry 48:21\u201329","journal-title":"Biol Psychiatry"},{"key":"506_CR8","doi-asserted-by":"crossref","unstructured":"Guy W (1976) ECDEU Assessment Manual for Psychopharmacology, Revised. United States Department of Health, Education, and Welfare, Bethesda, Md","DOI":"10.1037\/e591322011-001"},{"key":"506_CR9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1440-1754.1997.tb01015.x","volume":"33","author":"Hazell","year":"1997","unstructured":"Hazell P (1997) The overlap of attention deficit hyperactivity disorder with other common mental disorders. J P\u00e6diatr Child Health 33:131\u2013137","journal-title":"J P\u00e6diatr Child Health"},{"key":"506_CR10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.CHI.0000046908.27264.00","volume":"42","author":"Hazell","year":"2003","unstructured":"Hazell PL, Stuart JE (2003) A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry 42:886\u2013894","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"506_CR11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00004583-200102000-00007","volume":"40","author":"Jensen","year":"2001","unstructured":"Jensen PS (2001) Introduction\u2013ADHD comorbidity and treatment outcomes in the MTA. J Am Acad Child Adolesc Psychiatry 40:134\u2013136","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"506_CR12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00004583-200102000-00009","volume":"40","author":"Jensen","year":"2001","unstructured":"Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, March JS, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B (2001) ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 40:147\u2013158","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"506_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"506_CR14","unstructured":"Kaufman J, Birmaher B, Brent D, Rao U, Ryan N (1996) Kiddie-SADS-Present and Lifetime Version (K-SADS-PL). University of Pittsburgh Press, Pittsburgh"},{"key":"506_CR15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2307\/2531201","volume":"42","author":"Lachin","year":"1986","unstructured":"Lachin JM, Foulkes MA (1986) Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics 42:507\u2013519","journal-title":"Biometrics"},{"key":"506_CR16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-3223(02)01671-2","volume":"53","author":"Michelson","year":"2003","unstructured":"Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D (2003) Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 53:112\u2013120","journal-title":"Biol Psychiatry"},{"key":"506_CR17","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1176\/appi.ajp.159.11.1896","volume":"159","author":"Michelson","year":"2002","unstructured":"Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D (2002) Once-daily atomoxetine treatment for children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 159:1896\u20131901","journal-title":"Am J Psychiatry"},{"key":"506_CR18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/01.chi.0000125089.35109.81","volume":"43","author":"Michelson","year":"2004","unstructured":"Michelson D, Buitelaar J, Danckaerts MJ, Gillberg C, Spencer T, Zuddas A, Faries D, Zhang S (2004) Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 43:896\u2013904","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"506_CR19","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1542\/peds.108.5.e83","volume":"108","author":"Michelson","year":"2001","unstructured":"Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T, Atomoxetine ADHD Study Group (2001) Atomoxetine in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 108:e83","journal-title":"Pediatrics"},{"key":"506_CR20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.56.12.1097","volume":"56","author":"MTA","year":"1999","unstructured":"MTA Cooperative Group (1999) Development of clinical services for attention-deficit\/hyperactivity disorder. Arch Gen Psychiatry 56:1097\u20131099","journal-title":"Arch Gen Psychiatry"},{"key":"506_CR21","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/archpsyc.56.12.1088","volume":"56","author":"MTA","year":"1999","unstructured":"MTA Cooperative Group (1999) Moderators and mediators of treatment response for children with attention-deficit\/hyperactivity disorder. Arch Gen Psychiatry 56:1088\u20131096","journal-title":"Arch Gen Psychiatry"},{"key":"506_CR22","unstructured":"Newcorn J, Michelson D, Spencer T, Milton D (2002) Atomoxetine treatment in child\/adolescent ADHD with comorbid ODD. Presented at: The 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 22\u201327:2002; San Francisco, Calif"},{"key":"506_CR23","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00004583-198911000-00012","volume":"28","author":"Pliszka","year":"1989","unstructured":"Pliszka SR (1989) Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry 28:882\u2013887","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"506_CR24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1176\/ajp.155.5.693","volume":"155","author":"Spencer","year":"1998","unstructured":"Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones J, Harding M, Faraone SV,Seidman L (1998) Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 155:693\u2013695","journal-title":"Am J Psychiatry"},{"key":"506_CR25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4088\/JCP.v63n1209","volume":"63","author":"Spencer","year":"2002","unstructured":"Spencer TJ, Biederman J, Wilens TE, Faraone SV (2002) Novel treatments for attention-deficit\/hyperactivity disorder in children. J Clin Psychiatry 63 (Suppl 12):16\u201322","journal-title":"J Clin Psychiatry"},{"key":"506_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00004583-200301000-00006","volume":"42","author":"Walkup","year":"2003","unstructured":"Walkup JT, Labellarte MJ, Riddle MA, Pine D, Greenhill L, Klein R, Davies M, Sweeney M, Fu C, Abikoff H, Hack S, Klee B, McCracken J, Bergman L, Piacentini J, March J, Compton S, Robinson J, O\u2019Hara T, Baker S, Vitiello B, Ritz L, Roper M (2003) Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 42:13\u201321","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"506_CR27","first-page":"Recommendations","volume":"Helsinki","author":"World","year":"2000","unstructured":"World Medical Association (2000) Declaration of Helsinki: Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects. As adopted by the 18th General Assembly, Helsinki, Finland, June 1964 and amended by the 52nd General Assembly, Edinburgh, Scotland, October 2000","journal-title":"Declaration of"}],"container-title":["European Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-006-0506-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00787-006-0506-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-006-0506-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:33:19Z","timestamp":1559111599000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00787-006-0506-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1007\/s00787-006-0506-y","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}